Compugen Welcomes Dr. Elliott Sigal as Strategic Advisor, Prof. Drew Pardoll to US Subsidiary Board of Directors
News
Drug discovery company Compugen Ltd. announced the appointment of two immuno-oncology experts: former Bristol-Myers Squibb Executive Vice President and Director Elliott Sigal, M.D., Ph.D., has joined the company as a new strategic ... Read more